DIRS.INFO The most relevant business & tech news

☆ This risk assessment tool helped Olivia Munn discover her breast cancer
▼ + stars: | 2024-03-13 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +10 min

The “X-Men: Apocalypse” star, 43, wrote in an Instagram post Wednesday that she was diagnosed with breast cancer last year and would not have discovered it if her physician, Dr. Thaïs Aliabadi, had not calculated her breast cancer risk score. A breast cancer risk assessment tool uses a statistical model to estimate a woman’s risk of developing breast cancer over the next five years as well as over her lifetime, or up to about age 90, according to the National Cancer Institute. Two models are commonly used as breast cancer risk assessment tools: the Gail Model and the Tyrer-Cuzick Risk Assessment Calculator. An online version of the breast cancer risk assessment tool, using the Gail Model, is available for anyone to take at bcrisktool.cancer.gov. In fact, some women who do not develop breast cancer have higher risk estimates than some women who do develop breast cancer,” according to the National Cancer Institute’s website.

Persons: Olivia Munn’s, Thaïs Aliabadi, Aliabadi, Munn, Gail, Jennifer Plichta, “, ” Plichta, they’re, ”, Plichta, I’ve, they’ve, Otis Brawley, ” Brawley, Larry Norton, Evelyn H, ” Norton, Robert Smith, Ruth Oratz, NYU Langone Health’s, Dr, Sanjay Gupta, ” Oratz Organizations: CNN, National Cancer Institute, National Cancer, Duke Cancer Institute, Johns Hopkins University, Lauder Breast Center, Memorial Sloan Kettering Cancer Center, American Cancer Society, US Preventive Services Task Force, NYU, Cancer Center, NYU Grossman School of Medicine, CNN Health Locations: United States, Durham , North Carolina

☆ Mammography AI can cost patients extra. Is it worth it?
▼ + stars: | 2024-01-26 | by ( Michelle Andrews | Kff Health News | ) edition.cnn.com time to read: +8 min

In recent years, AI software that helps radiologists detect problems or diagnose cancer using mammography has been moving into clinical use. This extra review has enormous potential to improve the detection of suspicious breast masses and lead to earlier diagnoses of breast cancer. With RadNet’s AI tool, “it’s as if all patients get the benefit of our very top performer.”But is the tech analysis worth the extra cost to patients? The health system has developed AI models and is testing the technology with mammograms but doesn’t yet offer it to patients, she said. In the late 1980s and early 1990s, “computer-assisted detection” software promised to improve breast cancer detection.

Persons: “, ”, Etta Pisano, RadNet, Gregory Sorensen, Sorensen, generalists, ” Sorensen, Laura Heacock, NYU Langone Health’s, Heacock, it’s, Constance Lehman, ” Lehman, RadNet’s, Dr, Sanjay Gupta, Christoph Lee, mammography, Robert Smith, ” Smith, Smith, we’re Organizations: Health, American College of Radiology, NYU, Cancer, “, National Cancer Institute, FDA, Medicare, Services, CMS, Radiology, Massachusetts General Hospital, Harvard Medical School, Imaging Research, Mass, Get CNN, CNN Health, Screening, Research, University of Washington School of Medicine, American Cancer Society, Kaiser Health, KFF Locations: Manhattan, Baltimore, RadNet, New York, New Jersey, mammograms, Boston, Massachusetts, United States, Europe, Sweden, U.S

☆ NYU Langone Fired Him for His Anti-Hamas Posts. He’s Suing.
▼ + stars: | 2023-11-24 | by ( Joseph Goldstein | More About Joseph Goldstein | ) www.nytimes.com time to read: +8 min

A prominent doctor is suing NYU Langone Health after he was fired as director of its cancer center over his social media postings about the Israel-Hamas war. Dr. Neel is one of two doctors whom NYU Langone has removed for online postings since the war began last month. The lawsuit could put NYU Langone under the microscope in the widening debate. “They should take away their scholarships,” Dr. Grossman wrote in a message to Dr. Neel in October. In a statement, NYU Langone said Dr. Neel’s decision to share those emails was just him “lashing out for being held accountable.”“The emails referenced in the suit were among colleagues and Dr. Neel is now making them public in an effort to pressure NYU Langone,” the statement said.

Persons: NYU Langone —, Benjamin Neel, NYU Langone, Neel, Zaki Masoud, Masoud, Dr, “ Dr, Perlmutter, Milton Williams, ”, “, Ben Neel, ” Dr, Joseph Pace, Pace, Robert Grossman, Grossman —, —, Grossman, Neel’s, Williams, “ Grossman, Ben Organizations: NYU Langone Health, NYU Langone, NYU, Journalists, Palestine, Johns Hopkins Hospital, Lenox Hill Hospital, NYU Langone’s, Court, Perlmutter Cancer, Social Media Policy, Social Media, New, “, Harvard, Stanford, University of Pennsylvania Locations: Israel, New York, Gaza, Lenox, Mineola, Long, Manhattan, Connecticut

☆ An NYU cancer doc fired over Israel-Hamas war posts accuses the medical center of using him as a 'sacrificial lamb'
▼ + stars: | 2023-11-17 | by ( Natalie Musumeci | ) www.businessinsider.com time to read: +4 min

An NYU Langone Health cancer doctor has filed a lawsuit against the medical center. Benjamin Neel alleges that he was wrongly fired over posts he made related to the Israel-Hamas war. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . AdvertisementA renowned Jewish cancer biologist who was recently fired from NYU Langone Health has filed a lawsuit against the medical center, alleging that it used him as a "sacrificial lamb" by axing him over posts he made on social media related to the Israel-Hamas war. "Nonetheless, Dr. Ben Neel, as a leader at our institution, disregarded these standards in a series of public social media posts and later locked his Twitter/X account," Ritea said.

Persons: Benjamin Neel, Neel, —, axing, Steve Ritea, NYU Langone, Ritea, Dr, Ben Neel, Greta Thunberg, Milton Williams, besmirched, Williams Organizations: NYU, Health, Service, NYU Langone Health, Perlmutter Cancer, New, Court, New York University, NYU Langone, Israel Locations: Israel, New York City, New York, Palestine, Brooklyn , New York City

☆ New study suggests Black women should be screened earlier for breast cancer
▼ + stars: | 2023-04-19 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +12 min

CNN —A new study on breast cancer deaths raises questions around whether Black women should screen at earlier ages. Even though Black women have a 4% lower incidence rate of breast cancer than White women, they have a 40% higher breast cancer death rate. “When the breast cancer mortality rate for Black women in their 40s is 27 deaths per 100,000 person-years, this means 27 out of every 100,000 Black women aged 40-49 in the US die of breast cancer during one year of follow-up. They also wrote that health policy makers should pursue equity, not just equality, when it comes to breast cancer screening as a tool to help reduce breast cancer death rates. Having dense tissue in the breast can make it more difficult for radiologists to identify breast cancer on a mammogram, and women with dense breast tissue have a higher risk of breast cancer.

The Merck/Moderna collaboration is one of several combining powerful drugs that unleash the immune system to target cancers with mRNA vaccine technology. BioNTech SE (22UAy.DE) and Gritstone Bio Inc (GRTS.O) are working on competing cancer vaccines based on mRNA technology. Barr said it took about eight weeks to design a personalized mRNA vaccine for each patient. In the past, similar experimental cancer vaccines were developed targeting a single tumor mutation, or neoantigen. With mRNA technology in combination with Keytruda, "we can create this shotgun approach ... that can create a more potent immune response," Barr said.

The Merck/Moderna collaboration is one of several combining powerful drugs that unleash the immune system to target cancers with mRNA vaccine technology. BioNTech SE (22UAy.DE) and Gritstone Bio Inc (GRTS.O) are working on competing cancer vaccines based on mRNA technology. Barr said it took Moderna about eight weeks to design a personalized mRNA vaccine for each patient. In the past, similar experimental cancer vaccines were developed targeting a single tumor mutation, or neoantigen. With mRNA technology in combination with Keytruda, "we can create this shotgun approach ... that can create a more potent immune response," Barr said.

Search resuls for: "Perlmutter Cancer"

7 mentions found